Literature DB >> 28400888

Macular Evaluation wıth Spectral Domain Type Optic Coherence Tomography in Eyes with Acute Nonarteritic Ischemic Optic Neuropathy at the Presentation Visit.

Oya Donmez1, Gamze Kocaoglu1, Aylin Yaman1, Meltem Soylev Bajin1, Ali Osman Saatci1.   

Abstract

PURPOSE: To evaluate the macula with spectral domain type optic coherence tomography (OCT) in eyes with acute nonarteritic anterior ischemic optic neuropathy (NAION) at the presentation visit.
METHODS: Medical charts of the 133 patients who received the diagnosis of acute NAION between January 2008 and July 2014 at the Neuro-ophthalmology unit of Dokuz Eylul University were reviewed retrospectively. Sixtythree patients within 30 days of symptom onset with available baseline spectral domain type macular OCT were included in this study. Clinical and macular characteristics of the affected eye were assessed and compared to the fellow eyes.
RESULTS: Sixty-three eyes of 63 patients comprised the study group. Twenty one study eyes (33.3%) had normal posterior pole, 22 (34.9%) some evidence of subretinal fluid, 10 (15.8%) vitreomacular adhesion, five (7%) age-related macular degeneration related changes, four (6%) epiretinal membrane and one (1%) previous grid laser scars. On the other hand, 41 of 63 the fellow eyes (65%) had normal posterior pole, ten (15.8%), vitreomacular adhesion, seven (10.7%), age-related macular degeneration related changes, three (4%) epiretinal membrane and two (3%) other type of changes. OCT scan passing through the fovea exhibited 10 or more hyperreflective dots in 10 (15%) of the study eyes whereas two of the fellow eyes (3.2%) had 10 or more hyperreflective dots.
CONCLUSION: Macular OCT can be a part of the routine neuroophthalmologic examination in patients with acute NAION not only to show the NAION related changes such as the subretinal fluid accumulation but also to identify the other coexistent macular abnormalities.

Entities:  

Keywords:  Anti-VEGF agents; Macula; Nonarteritic ischemic optic neuropathy; Optic coherence tomography; Ranibizumab; Triamcinolone

Year:  2017        PMID: 28400888      PMCID: PMC5362975          DOI: 10.2174/1874364101711010017

Source DB:  PubMed          Journal:  Open Ophthalmol J        ISSN: 1874-3641


  19 in total

1.  Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-11

2.  Single intravitreal ranibizumab injection in eyes with acute non-arteritic anterior ischaemic optic neuropathy.

Authors:  Meltem Soylev Bajin; Ozlem Barut Selver; Okan Taskin; Aylin Yaman; Ali Osman Saatci
Journal:  Clin Exp Optom       Date:  2011-01-24       Impact factor: 2.742

3.  Macular star formation in diabetic patients with non-arteritic anterior ischemic optic neuropathy (NA-AION).

Authors:  Alberto Galvez-Ruiz
Journal:  Saudi J Ophthalmol       Date:  2014-09-16

4.  Macular thickness predictive of visual field sensitivity in ischaemic optic neuropathy.

Authors:  Taras Papchenko; Brian T Grainger; Peter J Savino; Greg D Gamble; Helen V Danesh-Meyer
Journal:  Acta Ophthalmol       Date:  2012-06-13       Impact factor: 3.761

5.  Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography.

Authors:  Gábor Gy Deák; Matthias Bolz; Katharina Kriechbaum; Sonja Prager; Georgios Mylonas; Christoph Scholda; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2010-01-15       Impact factor: 12.079

6.  Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography.

Authors:  Thomas R Hedges; Laurel N Vuong; Alberto O Gonzalez-Garcia; Carlos E Mendoza-Santiesteban; Maria Luz Amaro-Quierza
Journal:  Arch Ophthalmol       Date:  2008-06

7.  Early axonal damage detection by ganglion cell complex analysis with optical coherence tomography in nonarteritic anterior ischaemic optic neuropathy.

Authors:  Begoña Arana Larrea; Marta Galdos Iztueta; Lorea Martinez Indart; Nerea Martinez Alday
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-10       Impact factor: 3.117

8.  Single intravitreal aflibercept injection for unilateral acute nonarteritic ischemic optic neuropathy.

Authors:  Ziya Ayhan; Gamze Kocaoğlu; Aylin Yaman; Meltem Söylev Bajin; A Osman Saatci
Journal:  Case Rep Ophthalmol Med       Date:  2015-01-08

9.  Efficacy of intravitreal ranibizumab injection in acute nonarteritic ischemic optic neuropathy: a long-term follow up.

Authors:  Ali Osman Saatci; Okan Taskin; Ozlem Barut Selver; Aylin Yaman; Meltem Soylev Bajin
Journal:  Open Ophthalmol J       Date:  2013-09-30

Review 10.  Optical coherence tomography shows retinal abnormalities associated with optic nerve disease.

Authors:  Kirstin L Tawse; Thomas R Hedges; Marisa Gobuty; Carlos Mendoza-Santiesteban
Journal:  Br J Ophthalmol       Date:  2014-03-13       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.